This inventor holds 1 USPTO granted patent. Top assignee: B. Braun Melsungen Ag. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Joerg Nehne: Innovator in Isotonic Fat Emulsions
Introduction
Joerg Nehne is a notable inventor based in Guxhagen, Germany. He has made significant contributions to the field of nutrition and medical applications through his innovative work on isotonic fat emulsions. His research focuses on the incorporation of omega-3 fatty acids, omega-6 fatty acids, and medium-chain triglycerides, which have important implications for various medical conditions.
Latest Patents
Joerg Nehne holds a patent for an isotonic fat emulsion containing omega-3 fatty acids and its use. This patent describes emulsions that are particularly useful for parenteral application in post-aggression metabolism, chronic inflammatory diseases, and in neonatology and pediatrics. The unique combination of omega-3 fatty acids and medium-chain triglycerides allows for better oxidation in the organism, while protecting the omega-3 fatty acids from rapid oxidation. This ensures that they are available for the formation of triply unsaturated eicosanoids, providing a liver protective effect.
Career Highlights
Throughout his career, Joerg Nehne has been associated with B. Braun Melsungen AG, a leading company in the medical technology sector. His work has contributed to advancements in nutritional therapies and has had a positive impact on patient care.
Collaborations
Joerg Nehne collaborates with various professionals in his field, including his coworker Michael Boll. Their combined expertise enhances the development of innovative solutions in medical nutrition.
Conclusion
Joerg Nehne's contributions to the field of isotonic fat emulsions highlight the importance of innovation in medical applications. His work not only advances scientific knowledge but also improves patient outcomes in critical areas of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
